Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3
By Taija Mäkinen, Tanja Veikkola, S. Mustjoki, Terhi Karpanen, B. Catimel, E. Nice, Lyn M. Wise, A. Mercer, H. Kowalski, D. Kerjaschki and 3 more. EMBO Journal, 2001
874 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Physiology
View Paper: https://www.semanticscholar.org/paper/01c98ba2e8175bc1a707f1fc5c7a2acafc030a78
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
Citations in the corpus
- Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. (2018, background): “remodeling and extension, reorganizing themselves into a functional network of lymphatic vessels [3, 61].”
- Signal transduction by vascular endothelial growth factor receptors. (2012, background): “Another important pathway downstream of VEGFC/VEGFR3 is the PI3K/AKT pathway (Makinen et al. 2001), which may be critical in lymphendothelial cell migration.”
- The roles of vascular endothelial growth factor in bone repair and regeneration (2016, background): “VEGFR3 mainly binds to VEGF-C and VEGF-D in lymphatic endothelial cells, and plays an important role in regulation of lymphangiogenesis [30, 31].”
- Specialization of tumour vasculature (2002, neutral): “cgi?l=8828">neuropilin-2 , whereas lymphatic vessels in internal tissues do not, or do so at a level that is undetectable by current immunohistochemical method”
- Vascular Endothelial Growth Factor and Angiogenesis (2004, background): “VEGFR-3 activation leads to induction of PI3K and stimulation of Akt/PKB, which could be important for the survival of blood and lymphatic endothelial cells (Makinen et al., 2001).”